-
1 Comment
Kunming Longjin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.
From a valuation standpoint, the stock is 33.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.9.
Kunming Longjin Pharmaceutical Co., Ltd's total revenue rose by 11.9% to $64M since the same quarter in the previous year.
Its net income has increased by 735.4% to $4M since the same quarter in the previous year.
Finally, its free cash flow fell by 153.6% to $-5M since the same quarter in the previous year.
Based on the above factors, Kunming Longjin Pharmaceutical Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000021X8 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 453M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.22 |
| Dividend Yield | None |
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Kunming, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002750.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
